prod:prod_dcx-login
Xpert® Xpress Flu/RSV
Fast, accurate and reliable detection of Flu A, Flu B and/or RSV in one test
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
XPRSFLU/RSV-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Copan 3C057N (Nasopharyngeal Swab) (Pack of 50)
3C057N
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Copan 3C064N (Nasal Swab) (Pack of 50)
3C064N
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- Influenza and RSV are major causes of hospitalizations of both adults and children.1
- Influenza and RSV often present with similar symptoms, making it difficult to differentiate between the two infections2
- Sensitivities of rapid antigen detection tests (RADTs) for influenza and RSV range from 50–70% 3,4
- Reported sensitivity of RADTs for RSV is as low as 26%5
- Manufacturers of RADTs may recommend confirming Flu negative results with RT-PCR or culture.3
- Rapid RSV tests may have age limitations in their claims6
1 Hanage WP, Schaffner W. Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review. Infect Dis Ther. 2025;14(S1):5-37. doi:10.1007/s40121-024-01080-4
2 Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13.
3 CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed May 2025. https://www.cdc.gov/flu/hcp/testing-methods/clinician_guidance_ridt.html?CDC_AAref_Val=https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
4Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015
Dec;53(12):3738-49.
5 Bernstein DI, Mejias A, Rath B, Woods CW, Deeter JP. Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era. The Journal of Applied Laboratory Medicine. 2023;8(2):353-371. doi:10.1093/jalm/jfac058
6 https://www.accessdata.fda.gov/cdrh_docs/pdf10/K101918.pdf
2 Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13.
3 CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed May 2025. https://www.cdc.gov/flu/hcp/testing-methods/clinician_guidance_ridt.html?CDC_AAref_Val=https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
4Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015
Dec;53(12):3738-49.
5 Bernstein DI, Mejias A, Rath B, Woods CW, Deeter JP. Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era. The Journal of Applied Laboratory Medicine. 2023;8(2):353-371. doi:10.1093/jalm/jfac058
6 https://www.accessdata.fda.gov/cdrh_docs/pdf10/K101918.pdf
The Solution
- Accurate and reliable detection of Flu A, Flu B and RSV in as soon as 20 minutes* for patients of all ages
- Enables healthcare providers to quickly deliver targeted therapies and develop management plans related to isolation, vaccination and protecting staff
- Streamlines laboratory operations7
7 Hernandez, D. R., Pellitteri, G. P., Kimmich, D. J., Heiter, B. J., Smeal, K., & Wolk, D. M. (2019). Near point-of-care adoption of Cepheid Xpert® Flu/RSV XC testing within an integrated healthcare delivery network. Diagnostic microbiology and infectious disease, 94(1), 28–29.
* With early assay termination (EAT) for positive Flu or for positive RSV only. Reporting negatives and combined Flu and RSV results in approximately 30 minutes.
* With early assay termination (EAT) for positive Flu or for positive RSV only. Reporting negatives and combined Flu and RSV results in approximately 30 minutes.
The Impact
Single-test confidence can potentially accelerate your laboratory’s workflow with on-demand, random-access flexibility. Combine performance with the capability to run other Xpert® tests on Cepheid’s GeneXpert® system may support productivity increases in overall laboratory service.
Be Proactive
Be Proactive
- Achieve fast results and improve patient management
- Early assay termination option: deliver positive results for Flu or RSV only reporting in as soon as approx. 20 minutes* and negative results in approx. 30 minutes
- Quickly deliver targeted therapies and increase peace of mind for patients
Related Products
Xpert CT/NG
90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
Xpert Ebola
Accurate and Reliable Detection of Ebola Zaire Virus
Xpert Xpress Strep A
Delivers accurate and timely results that optimizes fast treatment decisions